Working Paper |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
Acquisitions and use of patents: A theory and new evidence from the Japanese firm level data |
0 |
0 |
0 |
29 |
0 |
0 |
0 |
114 |
An Analysis of Unilateral and Cross-licensing Based on an Inventor Survey in Japan: Effects of uncertainty, rent dissipation and a bundle of patents on corporate licenses |
0 |
0 |
0 |
31 |
1 |
1 |
1 |
73 |
An Economic Analysis of Deferred Examination System: Evidence from Policy Reforms in Japan |
0 |
1 |
2 |
43 |
0 |
1 |
3 |
107 |
Author ordering in scientific research: evidence from scientists survey in the US and Japan |
0 |
0 |
2 |
33 |
0 |
0 |
7 |
97 |
Claim Length as a Value Predictor of a Patent |
0 |
1 |
1 |
62 |
1 |
2 |
5 |
172 |
Coalition Formation for a Consortium Standard Through a Standard Body and a Patent Pool: Theory and Evidence from MPEG2, DVD and 3G |
0 |
0 |
4 |
113 |
0 |
3 |
8 |
324 |
Combining Knowledge and Capabilities across Borders and Nationalities: Evidence from the inventions applied through PCT |
0 |
0 |
0 |
29 |
0 |
0 |
2 |
36 |
Commercialization and Other Uses of Patents in Japan and the U.S.: Major findings from the RIETI-Georgia Tech inventor survey |
0 |
0 |
2 |
188 |
0 |
3 |
13 |
614 |
Complementarity, Fragmentation, and the Effects of Patent Thickets |
0 |
0 |
0 |
46 |
0 |
0 |
3 |
120 |
Complementary Reforms of Patent Examination Request System in Japan |
0 |
0 |
0 |
63 |
0 |
1 |
1 |
188 |
Contribution of Patent Examination to Making the Patent Scope Consistent with the Invention: Evidence from Japan |
0 |
0 |
0 |
27 |
0 |
0 |
1 |
62 |
Contributions of Corporate Basic Research and Research Collaboration with Academia to Innovation and Spillover Performance in Japan (Japanese) |
0 |
0 |
2 |
29 |
0 |
0 |
4 |
94 |
Contributions of young scholars in team-based scientific research |
0 |
0 |
0 |
26 |
0 |
0 |
0 |
131 |
Determinants of Firm Boundaries: Empirical Analysis of the Japanese Auto Industry from 1984 to 2002 |
0 |
0 |
1 |
66 |
0 |
0 |
1 |
208 |
Determinants of R&D and Its Productivity: Identifying Demand and Supply Channels (First revision) |
0 |
0 |
0 |
34 |
0 |
0 |
0 |
118 |
Determinants of high-royalty contracts and the impact of stronger protection of intellectual property rights in Japan |
0 |
0 |
0 |
122 |
1 |
1 |
1 |
420 |
Does the outsourcing of prior art search increase the efficiency of patent examination? |
0 |
0 |
0 |
53 |
0 |
1 |
4 |
225 |
Dynamic Effects of Patent Pools: Evidence from inter-generational competition in optical disk industry |
0 |
0 |
0 |
46 |
0 |
0 |
1 |
47 |
Early Disclosure and Patent Value: How do you know that you are a pioneer? |
0 |
1 |
21 |
21 |
1 |
2 |
31 |
31 |
Economics of Research Exemption |
0 |
0 |
0 |
31 |
0 |
0 |
0 |
162 |
Economics of Research Exemption |
0 |
0 |
0 |
5 |
1 |
2 |
3 |
35 |
Effects of early patent disclosure on knowledge dissemination: evidence from the pre-grant publication system introduced in the United States |
0 |
0 |
0 |
17 |
0 |
0 |
1 |
70 |
Exploring the Sources of Firm-level Scale Economies in R&D: Complementary assets, internal and external knowledge inflows, and inventor team size |
0 |
0 |
0 |
69 |
0 |
0 |
1 |
183 |
Firm Incubation through Business Group Affiliation: Acquisition and technology transaction (Japanese) |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
5 |
Firm Incubation through Business Group Affiliation: Acquisition and technology transaction (Japanese) |
0 |
0 |
0 |
8 |
0 |
0 |
0 |
3 |
Formation of a Pool with Essential Patents |
0 |
0 |
1 |
32 |
1 |
1 |
4 |
117 |
Global spread of pharmaceutical patent protections: micro evidence from the international equivalents of the drug patents in Japan |
0 |
0 |
0 |
77 |
0 |
0 |
1 |
57 |
How does Graduate Education Affect Inventive Performance? Evidence from undergraduates' choices during recessions |
0 |
0 |
0 |
17 |
0 |
0 |
1 |
44 |
How ’Open ’ is Innovation in the US and Japan?: Evidence from the RIETI-Georgia Tech inventor survey |
0 |
0 |
0 |
59 |
0 |
0 |
0 |
146 |
Impact of Patent Scope on subsequent Inventions: Findings from a new Measure |
0 |
0 |
0 |
43 |
0 |
0 |
3 |
83 |
Impacts of COVID-19 on R&D and Patenting Activities in Japan: Demand shocks, application delays, and patent option value (Japanese) |
1 |
1 |
1 |
7 |
3 |
3 |
3 |
19 |
Incentive Design for Inventors: Theory and empirical evidence (Japanese) |
0 |
0 |
0 |
33 |
1 |
1 |
2 |
112 |
Information Constraint of the Patent Office and Examination Quality: Evidence from the effects of initiation lags |
0 |
0 |
1 |
37 |
0 |
0 |
5 |
70 |
Initial Public Offering and Financing of Biotechnology Start-ups: Evidence from Japan |
0 |
0 |
0 |
42 |
2 |
2 |
2 |
93 |
Innovation Capability of Japanese Industry (Japanese) |
0 |
0 |
3 |
6 |
1 |
1 |
5 |
7 |
Innovation Process in Japan and the U.S.: Major findings from the RIETI inventor surveys (Japanese) |
0 |
0 |
0 |
7 |
0 |
0 |
0 |
32 |
Innovation Process in Japan in the Early 2000s as Seen from Inventors: Agenda for strengthening innovative capability (Japanese) |
0 |
0 |
0 |
27 |
0 |
1 |
5 |
82 |
Innovation Process in Japan: Findings from the RIETI Inventors Survey (Japanese) |
0 |
0 |
0 |
13 |
0 |
0 |
1 |
72 |
International Trade Aspects of Competition Policy |
0 |
0 |
0 |
262 |
0 |
0 |
0 |
1,288 |
Intrinsic and Extrinsic Motivations of Inventors |
0 |
0 |
1 |
73 |
1 |
1 |
10 |
301 |
Japanese Capability for Technological Innovation: Assessment and policy agenda for enhancement (Japanese) |
0 |
0 |
0 |
12 |
0 |
1 |
1 |
27 |
Knowledge Creation Process in Science: Basic findings from a large‐scale survey of researchers in Japan |
0 |
0 |
0 |
30 |
0 |
1 |
2 |
104 |
Knowledge Creation Process in Science: Key Comparative Findings from the Hitotsubashi-NISTEP-Georgia Tech Scientists' Survey in Japan and the US |
1 |
2 |
3 |
62 |
2 |
4 |
10 |
211 |
Language Barriers and the Speed of Knowledge Diffusion |
0 |
0 |
1 |
22 |
0 |
0 |
12 |
43 |
Life-cycle Productivity of Industrial Inventors: Education and other determinants |
0 |
0 |
1 |
37 |
1 |
1 |
5 |
292 |
Managerial and Policy Agenda for Improving Japanese R&D: Inventors' views (Japanese) |
0 |
0 |
0 |
5 |
1 |
1 |
2 |
101 |
Monetary Incentives for Corporate Inventors: Intrinsic motivation, project selection and inventive performance |
0 |
0 |
0 |
32 |
0 |
0 |
2 |
86 |
Ownership Structure and Productivity of Vertical Research Collaboration |
0 |
0 |
0 |
29 |
0 |
0 |
0 |
76 |
Patent quality, cumulative innovation and market value: Evidence from Japanese firm level panel data |
1 |
1 |
1 |
52 |
2 |
3 |
3 |
209 |
Productivity of Japanese Firms and Innovation System: Bolstering growth potential (Japanese) |
0 |
0 |
0 |
17 |
1 |
1 |
1 |
46 |
R&D and Market Value: Appropriability vs. Preemption |
0 |
0 |
0 |
40 |
2 |
2 |
6 |
177 |
Science-Based Business: Knowledge Capital or Entrepreneurial Ability? Theory and Evidence from a Survey of Biotechnology Start-ups |
0 |
0 |
0 |
16 |
0 |
0 |
1 |
114 |
Science-Based Business: Knowledge Capital or Entrepreneurial Ability?: Theory and Evidence from a Survey of Biotechnology Start-ups |
0 |
0 |
0 |
97 |
0 |
0 |
1 |
314 |
Scientific Sources of Corporate Inventions in Japan: Evidence from an inventor survey (Japanese) |
0 |
0 |
0 |
28 |
0 |
0 |
0 |
39 |
Spillover Effects of R&D in Japan (Japanese) |
0 |
0 |
1 |
5 |
1 |
1 |
2 |
9 |
Spillovers and Risk of R&D Projects, and Targeting of Public R&D Support (Japanese) |
0 |
0 |
0 |
15 |
0 |
0 |
0 |
57 |
Standards as a Knowledge Source for R&D: A first look at their incidence and impacts based on the inventor survey and patent bibliographic data |
0 |
0 |
0 |
41 |
0 |
0 |
1 |
121 |
The Consortium Standard and Patent Pools |
1 |
1 |
2 |
322 |
1 |
1 |
3 |
892 |
The Consortium Standard and Patent Pools |
0 |
0 |
0 |
26 |
1 |
1 |
3 |
144 |
The Consortium Standard and Patent Pools |
0 |
0 |
0 |
1 |
0 |
0 |
3 |
431 |
The Fourth Industrial Revolution and Japan's industrial innovative capability (Japanese) |
0 |
0 |
0 |
11 |
0 |
0 |
2 |
29 |
The R&D Process in the U.S. and Japan: Major findings from the RIETI-Georgia Tech inventor survey |
0 |
1 |
6 |
132 |
1 |
5 |
12 |
371 |
The Use of Science for Inventions and its Identification: Patent level evidence matched with survey |
0 |
1 |
1 |
22 |
0 |
1 |
2 |
63 |
The Utility Standard and the Patentability of Basic Research |
0 |
0 |
0 |
55 |
0 |
0 |
0 |
386 |
The Utility Standard and the Patentability of Intermediate Technology |
0 |
0 |
0 |
27 |
0 |
0 |
3 |
228 |
The Utility Standard and the Patentability of Intermediate Technology |
0 |
0 |
0 |
30 |
1 |
1 |
1 |
229 |
The structure and the evolution of essential patents for standards: Lessons from three IT standards |
0 |
0 |
0 |
43 |
0 |
0 |
1 |
187 |
Unilateral vs. cross licensing:A theory and new evidence on the firm-level determinants |
0 |
0 |
0 |
76 |
0 |
0 |
0 |
272 |
Use of Grace Periods and Their Impact on Knowledge Flow: Evidence from Japan |
0 |
0 |
0 |
25 |
0 |
0 |
3 |
76 |
Who Invents?: Evidence from the Japan-U.S. inventor survey |
0 |
0 |
4 |
114 |
1 |
3 |
16 |
610 |
バイオベンチャーの参入と成長 |
0 |
0 |
0 |
35 |
0 |
0 |
0 |
257 |
探索研究とサイエンス: 医薬イノベーションの科学的源泉とその経済効果に関する調査(1) |
0 |
0 |
0 |
21 |
1 |
1 |
1 |
144 |
日米上場企業の連結ベースでの多角化データベースの構築と基本的な知見 |
0 |
0 |
0 |
36 |
1 |
1 |
4 |
214 |
産学連携による知識創出とイノベーションの研究 -産学の共同発明者への大規模調査からの基礎的知見- |
0 |
0 |
7 |
67 |
0 |
0 |
17 |
281 |
臨床開発とサイエンス: 医薬イノベーションの科学的源泉とその経済効果に関する調査(2) |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
86 |
製薬企業とバイオベンチャーとのアライアンス: 日米欧製薬企業の比較分析 |
0 |
0 |
0 |
30 |
1 |
1 |
3 |
200 |
革新的な医薬の探索開発過程の事例研究: アクテムラ(JST-N-CASE01) |
0 |
0 |
1 |
69 |
1 |
1 |
2 |
200 |
革新的な医薬の探索開発過程の事例研究: コンパクチン(JST-N-CASE05) |
0 |
0 |
1 |
9 |
0 |
0 |
2 |
27 |
革新的な医薬の探索開発過程の事例研究: メバロチン(JST-N-CASE06) |
0 |
0 |
0 |
15 |
0 |
0 |
6 |
83 |
Total Working Papers |
4 |
10 |
71 |
3,643 |
34 |
59 |
267 |
13,598 |
Journal Article |
File Downloads |
Abstract Views |
Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
An Economic Analysis of Trade Friction: Economic Effects of the Dumping Control and the Result-Oriented Trade Policy |
0 |
0 |
1 |
19 |
0 |
0 |
1 |
115 |
An economic analysis of deferred examination system: Evidence from a policy reform in Japan |
0 |
0 |
0 |
12 |
0 |
0 |
0 |
66 |
Assessing the R&D Management of a Firm in Terms of Speed and Science Linkage: Evidence from the US Patents |
0 |
0 |
0 |
55 |
0 |
0 |
1 |
190 |
Benn Steil, David G. Victor, and Richard R. Nelson (eds.), Technological Innovation and Economic Performance |
0 |
0 |
1 |
17 |
0 |
0 |
1 |
51 |
Contribution of postdoctoral fellows to fast-moving and competitive scientific research |
0 |
0 |
0 |
6 |
1 |
1 |
1 |
31 |
Determinants of International Research Collaboration: Evidence from International Co-Inventions in Asia and Major OECD Countries |
0 |
0 |
0 |
12 |
2 |
2 |
5 |
51 |
Determinants of firm boundaries: Empirical analysis of the Japanese auto industry from 1984 to 2002 |
0 |
0 |
1 |
55 |
0 |
2 |
3 |
306 |
Determinants of high-royalty contracts and the impact of stronger protection of intellectual property rights in Japan |
0 |
0 |
0 |
27 |
1 |
1 |
3 |
134 |
Determinants of the Introduction of Stock Options by Japanese Firms: Analysis from the Incentive and Selection Perspectives |
0 |
0 |
0 |
84 |
1 |
1 |
1 |
322 |
Does Regional Integration Promote Global Liberalization? A Case of Endogenous Protection |
0 |
0 |
0 |
12 |
0 |
0 |
0 |
107 |
Does strong patent protection facilitate international technology transfer? Some evidence from licensing contracts of Japanese firms |
0 |
0 |
0 |
82 |
1 |
1 |
1 |
262 |
Does the outsourcing of prior art search increase the efficiency of patent examination? Evidence from Japan |
0 |
0 |
0 |
24 |
0 |
0 |
3 |
100 |
Dynamic Effects of Patent Pools: Evidence from Inter-Generational Competition in the Optical Disc Industry |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
3 |
EDITORS' INTRODUCTION |
0 |
0 |
0 |
2 |
0 |
1 |
1 |
47 |
EDITORS' INTRODUCTION |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
95 |
EDITORS' INTRODUCTION |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
92 |
Economic consequences of VIE when consumers are constrained |
0 |
0 |
0 |
6 |
0 |
0 |
2 |
57 |
Editors' introduction |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
132 |
Effects of early patent publication on knowledge dissemination: Evidence from U.S. patent law reform |
0 |
0 |
0 |
7 |
0 |
0 |
3 |
32 |
Global Spread of Pharmaceutical Patent Protection: Micro Evidence from the International Equivalents of Drug Patents in Japan |
0 |
0 |
0 |
3 |
0 |
0 |
0 |
27 |
Graduate education and long‐term inventive performance: Evidence from undergraduates' choices during recessions |
0 |
0 |
0 |
7 |
0 |
0 |
2 |
21 |
How Do Inventors Respond to Financial Incentives? Evidence from Unanticipated Court Decisions on Employees’ Inventions in Japan |
0 |
0 |
1 |
4 |
0 |
1 |
3 |
10 |
Impact of initial seeds on the growth of biotechnology startups: evidence from the U.S. and Japan |
0 |
0 |
1 |
9 |
0 |
0 |
3 |
27 |
Information constraints and examination quality in patent offices: The effect of initiation lags |
0 |
1 |
2 |
3 |
1 |
2 |
9 |
16 |
Initial public offering and financing of biotechnology start-ups: Evidence from Japan |
0 |
0 |
0 |
19 |
0 |
1 |
4 |
88 |
Innovative East Asia: The Future of Growth: By Shahid Yusuf et al. World Bank, Oxford Univ. Press, 2003 |
0 |
0 |
0 |
117 |
0 |
1 |
1 |
313 |
Making the patent scope consistent with the invention: Evidence from Japan |
0 |
0 |
1 |
5 |
0 |
0 |
2 |
30 |
Making university and industry research collaboration: Evidence from co-inventions in Japan |
0 |
0 |
2 |
6 |
0 |
0 |
3 |
11 |
Openness and innovation in the US: Collaboration form, idea generation and implementation |
0 |
0 |
2 |
43 |
0 |
0 |
4 |
201 |
R&D and market value of Japanese firms in the 1990s |
1 |
2 |
2 |
57 |
3 |
5 |
6 |
165 |
The Competitive Impact of International Trade: The Case of Import Liberalization of the Japanese Oil Product Market |
0 |
0 |
0 |
30 |
0 |
0 |
0 |
125 |
The Consortium Standard and Patent Pools |
0 |
0 |
0 |
33 |
0 |
0 |
2 |
117 |
The Innovation Process in Government Funded Research Consortia in Japan |
0 |
0 |
0 |
5 |
0 |
0 |
0 |
13 |
The Japanese Television Cartel: A Study Based on Matsushita v. Zenith, David Schwartzman, University of Michigan Press, Ann Arbor, MI, 1993, 197 pp., $39.50 |
0 |
0 |
2 |
53 |
0 |
0 |
2 |
240 |
The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan |
0 |
0 |
1 |
3 |
0 |
0 |
3 |
11 |
The incidence of cross-licensing: A theory and new evidence on the firm and contract level determinants |
0 |
0 |
1 |
52 |
0 |
0 |
6 |
186 |
Transition to the Market Economy through Integration to the World Economy―Interaction between Domestic Reform and Opening‐up― |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
9 |
Vertical Restraints and Market Access |
0 |
0 |
0 |
16 |
0 |
0 |
2 |
67 |
Total Journal Articles |
1 |
3 |
18 |
894 |
11 |
20 |
83 |
3,870 |